bendeka Teva’s cancer drug Bendeka protected from generics until 2031, judge rules By www.pharmafile.com Published On :: Thu, 30 Apr 2020 11:20:42 +0000 A US federal judge has ruled that generic versions of the cancer treatment Bendeka infringe on four separate patents, and has delayed them from launching until 2031. Full Article Bendeka Teva Teva and Eagle Business Services
